GAS5 and inflammatory bowel disease: Previous studies demonstrated lncRNA GAS5-AS1 as a tumor suppressor able to affect cancer pathogenesis, metastasis, prognosis, and survival [18, 19, 22]; however, no studies have evaluated its possible involvement in non-tumoral conditions, such as IBD.